266 related articles for article (PubMed ID: 7490538)
1. Similarities between hamster pancreatic islet beta (HIT) cell vasopressin receptors and V1b receptors.
Richardson SB; Laya T; VanOoy M
J Endocrinol; 1995 Oct; 147(1):59-65. PubMed ID: 7490538
[TBL] [Abstract][Full Text] [Related]
2. Effects of vasopressin on insulin secretion and inositol phosphate production in a hamster beta cell line (HIT).
Richardson SB; Eyler N; Twente S; Monaco M; Altszuler N; Gibson M
Endocrinology; 1990 Feb; 126(2):1047-52. PubMed ID: 2153517
[TBL] [Abstract][Full Text] [Related]
3. Effects of arginine vasopressin and oxytocin on glucagon release from clonal alpha-cell line In-R1-G9: involvement of V1b receptors.
Yibchok-anun S; Hsu WH
Life Sci; 1998; 63(21):1871-8. PubMed ID: 9825765
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach.
Oshikawa S; Tanoue A; Koshimizu TA; Kitagawa Y; Tsujimoto G
Mol Pharmacol; 2004 Mar; 65(3):623-9. PubMed ID: 14978240
[TBL] [Abstract][Full Text] [Related]
5. A V1-type receptor for mediating the neurohypophysial hormone-induced ACTH release in trout pituitary.
Pierson PM; Guibbolini ME; Lahlou B
J Endocrinol; 1996 Apr; 149(1):109-15. PubMed ID: 8676042
[TBL] [Abstract][Full Text] [Related]
6. 1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor.
Saito M; Tahara A; Sugimoto T
Biochem Pharmacol; 1997 Jun; 53(11):1711-7. PubMed ID: 9264324
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
[TBL] [Abstract][Full Text] [Related]
8. Effect of AVP and oxytocin on insulin release: involvement of V1b receptors.
Lee B; Yang C; Chen TH; al-Azawi N; Hsu WH
Am J Physiol; 1995 Dec; 269(6 Pt 1):E1095-100. PubMed ID: 8572202
[TBL] [Abstract][Full Text] [Related]
9. [1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.
Derick S; Cheng LL; Voirol MJ; Stoev S; Giacomini M; Wo NC; Szeto HH; Ben Mimoun M; Andres M; Gaillard RC; Guillon G; Manning M
Endocrinology; 2002 Dec; 143(12):4655-64. PubMed ID: 12446593
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor.
Thibonnier M; Auzan C; Madhun Z; Wilkins P; Berti-Mattera L; Clauser E
J Biol Chem; 1994 Feb; 269(5):3304-10. PubMed ID: 8106369
[TBL] [Abstract][Full Text] [Related]
11. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
[TBL] [Abstract][Full Text] [Related]
12. [Arg8]vasotocin excites neurones in the dorsal vagal complex in vitro: evidence for an action through novel class(es) of CNS receptors.
Ingram CD; Tolchard S
J Neuroendocrinol; 1994 Aug; 6(4):415-22. PubMed ID: 7987372
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic vasopressin V1b receptors: characterization in In-R1-G9 cells and localization in human pancreas.
Folny V; Raufaste D; Lukovic L; Pouzet B; Rochard P; Pascal M; Serradeil-Le Gal C
Am J Physiol Endocrinol Metab; 2003 Sep; 285(3):E566-76. PubMed ID: 12736162
[TBL] [Abstract][Full Text] [Related]
14. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
Croiset G; De Wied D
Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin-induced calcium signaling in cultured hippocampal neurons.
Brinton RD; Gonzalez TM; Cheung WS
Brain Res; 1994 Oct; 661(1-2):274-82. PubMed ID: 7834378
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.
Tahara A; Saito M; Sugimoto T; Tomura Y; Wada K; Kusayama T; Tsukada J; Ishii N; Yatsu T; Uchida W; Tanaka A
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):63-9. PubMed ID: 9459574
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of vasotocin stimulation of phosphoinositide turnover in frog adrenal gland.
Larcher A; Delarue C; Homo-Delarche F; Kikuyama S; Kupryszewski G; Vaudry H
Endocrinology; 1992 Jan; 130(1):475-83. PubMed ID: 1309345
[TBL] [Abstract][Full Text] [Related]
18. Frog glomerular vasotocin receptors resemble mammalian V1b receptors.
Ammar A; Rajerison RM; Roseau S; Bloch-Faure M; Butlen D
Am J Physiol; 1994 Nov; 267(5 Pt 2):R1198-208. PubMed ID: 7977846
[TBL] [Abstract][Full Text] [Related]
19. The vasopressin-induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling.
Reymond-Marron I; Tribollet E; Raggenbass M
Eur J Neurosci; 2006 Sep; 24(6):1565-74. PubMed ID: 17004920
[TBL] [Abstract][Full Text] [Related]
20. Vasotocin and vasopressin stimulation of the chloride secretion in the human bronchial epithelial cell line, 16HBE14o-.
Bernard K; Bogliolo S; Ehrenfeld J
Br J Pharmacol; 2005 Apr; 144(8):1037-50. PubMed ID: 15685210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
